p53 induces distinct epigenetic states at its direct target promoters

BMC Genomics

Volumn 9, Issue , 2008, Pages

  Vrba, Lukas ^a,c   Junk, Damian J ^a,b   Novak, Petr ^a,c   Futscher, Bernard W ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c INSTITUTE OF PLANT MOLECULAR BIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DIACYLGLYCEROL KINASE; DIACYLGLYCEROL KINASE ZETA; DNA; F BOX PROTEIN; F BOX PROTEIN 22; GROWTH DIFFERENTIATION FACTOR 9; HISTIDINE; HISTONE; LYSINE; PROTEIN P53; SERINE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BREAST EPITHELIUM; CELL IMMORTALIZATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MUTANT; PROMOTER REGION; PROTEIN DNA BINDING; WILD TYPE; CELL LINE; GENETIC EPIGENESIS; GENETICS; HUMAN GENOME; METABOLISM; MUTATION; PROTEIN BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLATION; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; EPIGENESIS, GENETIC; GENOME, HUMAN; HISTONES; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 56749169365     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-9-486     Document Type: Article

References (52)

1. Barlev NA Liu L Chehab NH Mansfield K Harris KG Halazonetis TD Berger SL Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases Mol Cell 2001, 8(6):1243-1254. 11779500
2. Espinosa JM Emerson BM Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment Mol Cell 2001, 8(1):57-69. 11511360
3. Espinosa JM Verdun RE Emerson BM p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage Mol Cell 2003, 12(4):1015-1027. 14580351
4. Kaeser MD Iggo RD Promoter-specific p53-dependent histone acetylation following DNA damage Oncogene 2004, 23(22):4007-4013. 15007388
5. Lagger G Doetzlhofer A Schuettengruber B Haidweger E Simboeck E Tischler J Chiocca S Suske G Rotheneder H Wintersberger E et al The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene Mol Cell Biol 2003, 23(8):2669-2679. 152549 12665570
6. Liu G Xia T Chen X The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/ CREB-binding protein J Biol Chem 2003, 278(19):17557-17565. 12609999
7. Shan B Xu J Zhuo Y Morris CA Morris GF Induction of p53-dependent activation of the human proliferating cell nuclear antigen gene in chromatin by ionizing radiation J Biol Chem 2003, 278(45):44009-44017. 12947108
8. Magrini R Russo D Fronza G Inga A Menichini P The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage J Cell Biochem 2007, 100(5):1276-1287. 17063487
9. Esteve PO Chin HG Pradhan S Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells J Biol Chem 2007, 282(4):2615-2625. 17124180
10. Imbriano C Gurtner A Cocchiarella F Di Agostino S Basile V Gostissa M Dobbelstein M Del Sal G Piaggio G Mantovani R Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters Mol Cell Biol 2005, 25(9):3737-3751. 1084283 15831478
11. Murphy M Ahn J Walker KK Hoffman WH Evans RM Levine AJ George DL Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a Genes Dev 1999, 13(19):2490-2501. 317076 10521394
12. Nguyen TT Cho K Stratton SA Barton MC Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene Mol Cell Biol 2005, 25(6):2147-2157. 1061614 15743813
13. Wu Y Mehew JW Heckman CA Arcinas M Boxer LM Negative regulation of bcl-2 expression by p53 in hematopoietic cells Oncogene 2001, 20(2):240-251. 11313951
14. Hoh J Jin S Parrado T Edington J Levine AJ Ott J The p53MH algorithm and its application in detecting p53-responsive genes Proc Natl Acad Sci USA 2002, 99(13):8467-8472. 124275 12077306
15. Jen KY Cheung VG Identification of novel p53 target genes in ionizing radiation response Cancer Res 2005, 65(17):7666-7673. 16140933
16. Krieg AJ Hammond EM Giaccia AJ Functional analysis of p53 binding under differential stresses Mol Cell Biol 2006, 26(19):7030-7045. 1592883 16980608
17. Miled C Pontoglio M Garbay S Yaniv M Weitzman JB A genomic map of p53 binding sites identifies novel p53 targets involved in an apoptotic network Cancer Res 2005, 65(12):5096-5104. 15958553
18. Wang L Wu Q Qiu P Mirza A McGuirk M Kirschmeier P Greene JR Wang Y Pickett CB Liu S Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches J Biol Chem 2001, 276(47):43604-43610. 11571296
19. Wei CL Wu Q Vega VB Chiu KP Ng P Zhang T Shahab A Yong HC Fu Y Weng Z et al A global map of p53 transcription-factor binding sites in the human genome Cell 2006, 124(1):207-219. 16413492
20. Smeenk L van Heeringen SJ Koeppel M Driel MA Bartels SJ Akkers RC Denissov S Stunnenberg HG Lohrum M Characterization of genome-wide p53-binding sites upon stress response Nucleic Acids Res 2008, 36(11):3639-3654. 2441782 18474530
21. Pavletich NP Chambers KA Pabo CO The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots Genes Dev 1993, 7(12B):2556-2564. 8276238
22. Unger T Nau MM Segal S Minna JD p53: A transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer EMBO J 1992, 11(4):1383-1390. 556587 1314165
23. Vogelstein B Lane D Levine AJ Surfing the p53 network Nature 2000, 408(6810):307-310. 11099028
24. Cho Y Gorina S Jeffrey PD Pavletich NP Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations Science 1994, 265(5170):346-355. 8023157
25. Elledge RM Allred DC The p53 tumor suppressor gene in breast cancer Breast Cancer Res Treat 1994, 32(1):39-47. 7819584
26. Iacopetta B Grieu F Powell B Soong R McCaul K Seshadri R Analysis of p53 gene mutationby polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer Clin Cancer Res 1998, 4(7):1597-1602. 9676832
27. Runnebaum IB Nagarajan M Bowman M Soto D Sukumar S Mutations in p53 as potential molecular markers for human breast cancer Proc Natl Acad Sci USA 1991, 88(23):10657-10661. 52989 1961733
28. Sjogren S Inganas M Norberg T Lindgren A Nordgren H Holmberg L Bergh J The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry J Natl Cancer Inst 1996, 88(3-4):173-182. 8632491
29. O'Farrell TJ Ghosh P Dobashi N Sasaki CY Longo DL Comparison of the effect of mutant and wild-type p53 on global gene expression Cancer Res 2004, 64(22):8199-8207. 15548685
30. Scian MJ Stagliano KE Ellis MA Hassan S Bowman M Miles MF Deb SP Deb S Modulation of gene expression by tumor-derived p53 mutants Cancer Res 2004, 64(20):7447-7454. 15492269
31. Tepper CG Gregg JP Shi XB Vinall RL Baron CA Ryan PE Desprez PY Kung HJ deVere White RW Profiling of gene expression changes caused by p53 gain-of-function mutant alleles in prostate cancer cells Prostate 2005, 65(4):375-389. 16037992
32. Weisz L Zalcenstein A Stambolsky P Cohen Y Goldfinger N Oren M Rotter V Transactivation of the EGR1 gene contributes to mutant p53 gain of function Cancer Res 2004, 64(22):8318-8327. 15548700
33. Zalcenstein A Weisz L Stambolsky P Bar J Rotter V Oren M Repression of the MSP/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53 Oncogene 2006, 25(3):359-369. 16170349
34. Di Agostino S Strano S Emiliozzi V Zerbini V Mottolese M Sacchi A Blandino G Piaggio G Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation Cancer Cell 2006, 10(3):191-202. 16959611
35. Junk DJ Vrba L Watts GS Oshiro MM Martinez JD Futscher BW Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells Neoplasia 2008, 10(5):450-461. 2373910 18472962
36. Soussi T Rubio-Nevado JM Hamroun D Béroud C The p53 Mutation Handbook; 2007. http://p53.free.fr
37. Odom DT Zizlsperger N Gordon DB Bell GW Rinaldi NJ Murray HL Volkert TL Schreiber J Rolfe PA Gifford DK Control of pancreas and liver gene expression by HNF transcription factors Science 2004, 303(5662):1378-1381. 14988562
38. Nouzova M Holtan N Oshiro MM Isett RB Munoz-Rodriguez JL List AF Narro ML Miller SJ Merchant NC Futscher BW Epigenomic changes during leukemia cell differentiation: Analysis of histone acetylation and cytosine methylation using CpG island microarrays J Pharmacol Exp Ther 2004, 311(3):968-981. 15302897
39. Oshiro MM Watts GS Wozniak RJ Junk DJ Munoz-Rodriguez JL Domann FE Futscher BW Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression Oncogene 2003, 22(23):3624-3634. 12789271
40. el-Deiry WS Tokino T Waldman T Oliner JD Velculescu VE Burrell M Hill DE Healy E Rees JL Hamilton SR et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues Cancer Res 1995, 55(13):2910-2919. 7796420
41. Hoeller C Thallinger C Pratscher B Bister MD Schicher N Loewe R Heere-Ress E Roka F Sexl V Pehamberger H The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cells J Invest Dermatol 2005, 124(6):1293-1299. 15955106
42. Muthusamy V Duraisamy S Bradbury CM Hobbs C Curley DP Nelson B Bosenberg M Epigenetic silencing of novel tumor suppressors in malignant melanoma Cancer Res 2006, 66(23):11187-11193. 17145863
43. Toyama T Iwase H Yamashita H Hara Y Omoto Y Sugiura H Zhang Z Fujii Y Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer Cancer Lett 2003, 189(1):97-102. 12445683
44. Wang L Duke L Zhang PS Arlinghaus RB Symmans WF Sahin A Mendez R Dai JL Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer Cancer Res 2003, 63(15):4724-4730. 12907655
45. Hanavadi S Martin TA Watkins G Mansel RE Jiang WG The role of growth differentiation factor-9 (GDF-9) and its analog, GDF-9b/BMP-15, in human breast cancer Ann Surg Oncol 2007, 14(7):2159-2166. 17453295
46. Los AP Vinke FP de Widt J Topham MK van Blitterswijk WJ Divecha N The retinoblastoma family proteins bind to and activate diacylglycerol kinase zeta J Biol Chem 2006, 281(2):858-866. 16286473
47. Cenciarelli C Chiaur DS Guardavaccaro D Parks W Vidal M Pagano M Identification of a family of human F-box proteins Curr Biol 1999, 9(20):1177-1179. 10531035
48. Wozniak RJ Klimecki WT Lau SS Feinstein Y Futscher BW 5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation Oncogene 2007, 26(1):77-90. 16799634
49. Novak P Jensen T Oshiro MM Wozniak RJ Nouzova M Watts GS Klimecki WT Kim C Futscher BW Epigenetic inactivation of the HOXA gene cluster in breast cancer Cancer Res 2006, 66(22):10664-10670. 17090521
50. Smyth GK Limma: Linear models for microarray data Bioinformatics and Computational Biology Solutions using R and Bioconductor New York: Springer Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W 2005:397-420.
51. R_Development_Core_Team R: A language and environment for statistical computing R Foundation for Statistical Computing 2007 http://www.R-project.org
52. Fury W Batliwalla F Gregersen PK Li W Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion Conf Proc IEEE Eng Med Biol Soc 2006, 1:5531-5534. 17947148